Latest News and Press Releases

ALLSCHWIL/BASEL, SWITZERLAND - 07 March 2017 - Actelion Ltd (SIX: ATLN) announced today that the European Commission has granted marketing authorization for the use of Ledaga® (chlormethine gel) 160...

ALLSCHWIL, SWITZERLAND - 02 March 2017 - Actelion (SIX: ATLN) announced today that Japan's Ministry of Health, Labor and Welfare granted a label extension for dosage and administration for...

ALLSCHWIL, SCHWEIZ - 2. März 2017 - Actelion (SIX: ATLN) gab heute bekannt, dass das japanische Ministerium für Gesundheit, Arbeit und Soziales eine Dosierungs- und Anwendungserweiterung für...

ALLSCHWIL/BASEL, SWITZERLAND - 16 February 2017 - Actelion Ltd (SIX: ATLN) today announced that Janssen Holding GmbH, a Swiss subsidiary of Johnson & Johnson (NYSE:JNJ), has published the Offer...

ALLSCHWIL/BASEL, SCHWEIZ - 14. Februar 2017 - Actelion Ltd (SIX: ATLN) gab heute die Ergebnisse für das Geschäftsjahr 2016 bekannt. FINANZÜBERBLICK Umsatz wächst auf CHF 2412 Millionen (+15%...

ALLSCHWIL/BASEL, SWITZERLAND - 14 February 2017 - Actelion Ltd (SIX: ATLN) today announced its results for the full year 2016. FINANCIAL HIGHLIGHTS Sales growing to CHF 2,412 million (+15% at...

ALLSCHWIL/BASEL, SWITZERLAND - 10 February 2017 - Actelion Ltd (SIX: ATLN) today announced that it has concluded the share repurchase program on a second trading line at the SIX Swiss Exchange on 10...

ALLSCHWIL/BASEL, SCHWEIZ - 10. Februar 2017 - Actelion Ltd (SIX: ATLN) gab heute bekannt, dass das am 9. April 2015 begonnene Aktienrückkaufprogramm auf einer separaten Handelslinie an der SIX Swiss...

In the previous press release the companies omitted the cash amount with which R&D NewCo will launch. This has now been rectified and noted as CHF 1 billion. Actelion Shareholders to Receive...